Subscribe To

Price Alert Latest News Economic Calendar News

EAR / EAR: Berman Tabacco Alerts Investors with Losses in Excess of $100,000 of Deadline for Seeking Appointment as Lead Plaintiff in Eargo, Inc. Class Action

EAR: Berman Tabacco Alerts Investors with Losses in Excess of $100,000 of Deadline for Seeking Appointment as Lead Plaintiff in Eargo, Inc. Class Action

Boston, Massachusetts--(Newsfile Corp. - October 7, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Eargo, Inc. ("Eargo" or the "Company") (NASDAQ: EAR), a medical device company focused on hearing aids with headquarters in San Jose, California. On October 16, 2020, the Company commenced its initial public offering selling approximately 9 million shares of common stock at $18 per share for net proceeds of approximately $148 million.About... Read More

Demo Live Account See Partner Details

Content Topics

EAR

Berman

Tabacco

Alerts

Investors

With

Losses

Excess

100 000

Deadline

Seeking

Appointment

Plaintiff

Eargo

Action

Stock

Posted: Oct 7 2021, 10:48

Author Name: Newsfile Corp

EAR News

By InvestorPlace
October 30, 2023

Why Is Eargo (EAR) Stock Up 50% Today?

Eargo (NASDAQ: EAR ) stock is jumping more than 50% on Oct. 30 after the company agreed to be taken private by Patient Square Capital . The deal is va

By Seeking Alpha
May 11, 2023

Eargo, Inc. (EAR) Q1 2023 Earnings Call Transcript

Eargo, Inc. (NASDAQ:EAR ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Nick Laudico - Chief Retail Officer Christian

By Seeking Alpha
March 23, 2023

Eargo, Inc. (EAR) Q4 2022 Earnings Call Transcript

Eargo, Inc. (NASDAQ:EAR ) Q4 2022 Earnings Call Transcript March 23, 2023 4:30 PM ET Company Participants Nick Laudico - Chief Retail Officer Christia

By GlobeNewsWire
March 17, 2023

Eargo to Report Fourth Quarter 2022 Financial Results on March 23, 2023

SAN JOSE, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today

By Seeking Alpha
February 10, 2023

Eargo Seeks To Reignite Revenue Growth After Major Stumble

Eargo, Inc. went public in October 2020, raising approximately $141 million in a U.S. IPO. The firm sells advanced hearing aid products in the United

By InvestorPlace
January 17, 2023

Wednesday Predictions: 3 Hot Stocks for Tomorrow

Now more than ever, it seems like investors are glued to the financial news. Not just because it's interesting, but because we've been in a tough bear

By Investors Business Daily
January 6, 2023

Over-The-Counter Hearing Aids Something To Shout About

Numerous companies at CES 2023 have jumped into the potentially lucrative market for over-the-counter hearing aids, including Eargo, Jabra and Nuheara

By Seeking Alpha
November 6, 2022

Eargo, Inc. (EAR) CEO Christian Gormsen on Q3 2022 Results - Earnings Call Transcript

Eargo, Inc. (NASDAQ:EAR ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Nick Laudico - Senior Vice President, Corp

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.